Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Claeys

Showing results (161-170 of 239) with videos related to

Pageof 24
Sort By:
Acta Clinica Belgica|July 17, 2014
Implementation of a multidisciplinary infectious diseases team in a tertiary hospital within an Antimicrobial Stewardship ProgramF M Buyle, M Wallaert, N Beck, et al.
Neurology|March 15, 2006
Novel mutations in the HSN2 gene causing hereditary sensory and autonomic neuropathy type IIK Coen, D Pareyson, M Auer-Grumbach, et al.
European Journal of Neurology|March 20, 2024
Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measuresBram De Wel, Louise Iterbeke, Lotte Huysmans, et al.
Neuromuscular Disorders : NMD|December 24, 2005
Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IVNathalie Verpoorten, Kristl G Claeys, Liesbet Deprez, et al.
Neurology|March 10, 2015
Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathyWerner Stenzel, Corinna Preuße, Yves Allenbach, et al.
Annals of the Rheumatic Diseases|December 26, 2022
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodiesJean-Baptiste Vulsteke, Rita Derua, Sylvain Dubucquoi, et al.
Neuromuscular Disorders : NMD|July 26, 2008
Electron microscopy in myofibrillar myopathies reveals clues to the mutated geneK G Claeys, M Fardeau, R Schröder, et al.
Journal of Patient-Reported Outcomes|November 13, 2024
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe diseasePriya S Kishnani, Barry J Byrne, Kristl G Claeys, et al.
Journal of Neurology|October 9, 2013
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathyMaike F Dohrn, Christoph Röcken, Jan L De Bleecker, et al.
Neuropathology and Applied Neurobiology|November 11, 2010
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganizationJ A Bevilacqua, N Monnier, M Bitoun, et al.
Pageof 24

Showing results (161-170 of 239) with videos related to

Sort By:
Pageof 24
Acta Clinica Belgica|July 17, 2014
Implementation of a multidisciplinary infectious diseases team in a tertiary hospital within an Antimicrobial Stewardship ProgramF M Buyle, M Wallaert, N Beck, et al.
Neurology|March 15, 2006
Novel mutations in the HSN2 gene causing hereditary sensory and autonomic neuropathy type IIK Coen, D Pareyson, M Auer-Grumbach, et al.
European Journal of Neurology|March 20, 2024
Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measuresBram De Wel, Louise Iterbeke, Lotte Huysmans, et al.
Neuromuscular Disorders : NMD|December 24, 2005
Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IVNathalie Verpoorten, Kristl G Claeys, Liesbet Deprez, et al.
Neurology|March 10, 2015
Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathyWerner Stenzel, Corinna Preuße, Yves Allenbach, et al.
Annals of the Rheumatic Diseases|December 26, 2022
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodiesJean-Baptiste Vulsteke, Rita Derua, Sylvain Dubucquoi, et al.
Neuromuscular Disorders : NMD|July 26, 2008
Electron microscopy in myofibrillar myopathies reveals clues to the mutated geneK G Claeys, M Fardeau, R Schröder, et al.
Journal of Patient-Reported Outcomes|November 13, 2024
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe diseasePriya S Kishnani, Barry J Byrne, Kristl G Claeys, et al.
Journal of Neurology|October 9, 2013
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathyMaike F Dohrn, Christoph Röcken, Jan L De Bleecker, et al.
Neuropathology and Applied Neurobiology|November 11, 2010
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganizationJ A Bevilacqua, N Monnier, M Bitoun, et al.
Pageof 24